Bora Pharmaceuticals Co., Ltd. (TPE:6472)
Taiwan · Delayed Price · Currency is TWD 405.00
+0.50 (0.12%)
Aug 19, 2026, 1:30 PM CST
Bora Pharmaceuticals Market Cap
Bora Pharmaceuticals has a market cap or net worth of 51.58 billion as of August 19, 2026. Its market cap has decreased by -46.58% in one year.
Market Cap
51.58B
Enterprise Value
65.03B
Revenue
19.56B
Ranking
n/a
PE Ratio
42.13
Stock Price
405.00
ChartMarket Cap Chart
Since October 3, 2014, Bora Pharmaceuticals's market cap has increased from 3.16B to 51.58B, an increase of 1,531.37%. That is a compound annual growth rate of 26.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2026 | 51.58B | -14.77% |
| Dec 31, 2025 | 60.52B | -22.12% |
| Dec 31, 2024 | 77.71B | 20.27% |
| Dec 29, 2023 | 64.61B | 107.61% |
| Dec 30, 2022 | 31.12B | 150.04% |
| Dec 30, 2021 | 12.45B | 17.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lotus Pharmaceutical | 48.99B |
| Center Laboratories | 25.04B |
| TTY Biopharm Company | 19.00B |
| Synmosa Biopharma | 16.19B |
| ScinoPharm Taiwan | 14.87B |
| YungShin Global Holding | 14.49B |
| Grape King Bio | 13.21B |
| Handa Pharmaceuticals | 12.76B |